Determining how neural activity impairs bioenergetics in PD pathogenesis
确定神经活动如何损害 PD 发病机制中的生物能学
基本信息
- 批准号:9257471
- 负责人:
- 金额:$ 42.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAxonBehaviorBioenergeticsBiological AssayBrainCell RespirationCellsCessation of lifeChronicComplexConsumptionCorpus striatum structureDataDefectDependovirusDopamineDoxycyclineFailureFunctional disorderGeneticGlycolysisGoalsImpairmentIn VitroIndividualLeadMeasuresMethodsMidbrain structureMitochondriaMitochondrial ProteinsMusMutationNerve BlockNerve DegenerationNeuronsPINK1 genePTEN-induced putative kinaseParkinson DiseasePathogenesisPharmacogeneticsPlayPresynaptic TerminalsPreventive treatmentProcessProductionRattusResearch PersonnelRespiratory physiologyRoleSubstantia nigra structureSynapsesSynaptic VesiclesTestingToxic effectTranslatingWorkbasecohortdesigndesigner receptors exclusively activated by designer drugsdopaminergic neuronin vivoinnovationinsightkillingsmitochondrial dysfunctionmyelinationnervous system disorderneuron losspostnatalpublic health relevancerelating to nervous systemstressortherapeutic targettoolvesicular release
项目摘要
DESCRIPTION (provided by applicant): Parkinson's disease (PD) is a progressive neurological disorder in which dopamine (DA) neurons in the brain degenerate and die. A genetic form of PD is caused by mutations in the mitochondrial protein PINK1, which proves that DA neurons are selectively vulnerable to specific mitochondrial stressors. Interestingly, considerable evidence suggests that mitochondrial function is also disrupted in sporadic (rather than genetic) forms of PD, and these changes may also selectively kill DA neurons. So, why are DA neurons susceptible to mitochondrial dysfunction? Because a critical role of mitochondria is to produce energy, many researchers believe that DA neurons are susceptible to energy failure. For example, DA neurons may not be able to produce as much energy or they might require more energy than other types of neurons. Indeed, much of the brain's energy is dedicated to supporting neural activity, and the activity of DA neurons may increase in PD. However, although many believe that energy failure plays a central role in PD pathophysiology, we know remarkably little about energy levels in DA neurons; we don't know if energy failure even occurs in these cells. In order to investigate energy failure in DA neurons, we developed innovative assays to measure ATP and visualize mitochondria in individual neurons. With these methods, we can now test our central hypothesis that DA neurons intrinsically require more energy than other types of neurons to sustain their neural activity, making them particularly susceptible to insults that further increase their energy demands or compromise mitochondrial function. The overall objective of the proposed study is to understand if DA neurons have intrinsic differences in the way they produce or consume energy that make them susceptible to energy failure. We will accomplish these objectives in three specific aims. (1) We will determine if DA neurons have intrinsic deficits in mitochondrial bioenergetic function at the synapse. To do this, we will measure energy production and consumption in individual DA neurons with our newly developed assays to evaluate mitochondrial energy levels in individual synaptic boutons. (2) We will determine if and how loss of the PD protein PINK1 compromises bioenergetic function in DA neurons by determining how losing PINK1 affects these neurons' mitochondrial distribution and function. (3) We will determine if the level of neural activity makes DA neurons even more susceptible to energy failure by assessing their function and death after changing activity levels.
Overall, these studies will advance our understanding of if and how energy failure develops in DA neurons, and they will provide insight into how we might therapeutically target energy failure in PD.
描述(申请人提供):帕金森病(PD)是一种进行性神经系统疾病,大脑中的多巴胺(DA)神经元退化和死亡。帕金森病的一种遗传形式是由线粒体蛋白PINK1的突变引起的,这证明DA神经元选择性地易受特定线粒体应激源的影响。有趣的是,相当多的证据表明,散发性(而不是遗传性)帕金森病的线粒体功能也被破坏,这些变化也可能选择性地杀死DA神经元。那么,为什么DA神经元容易受到线粒体功能障碍的影响?由于线粒体的关键作用是产生能量,许多研究人员认为DA神经元容易受到能量衰竭的影响。例如,DA神经元可能不能产生同样多的能量,或者它们可能比其他类型的神经元需要更多的能量。事实上,大脑的大部分能量都致力于支持神经活动,而帕金森病患者DA神经元的活动可能会增加。然而,尽管许多人认为能量衰竭在帕金森病的病理生理学中起着核心作用,但我们对DA神经元的能量水平知之甚少;我们甚至不知道这些细胞是否发生了能量衰竭。为了研究DA神经元中的能量衰竭,我们开发了创新的方法来测量ATP并可视化单个神经元中的线粒体。通过这些方法,我们现在可以检验我们的中心假设,即DA神经元固有地比其他类型的神经元需要更多的能量来维持其神经活动,使它们特别容易受到进一步增加其能量需求或损害线粒体功能的侮辱。这项拟议研究的总体目标是了解DA神经元在产生或消耗能量的方式上是否存在内在差异,从而使它们容易受到能量衰竭的影响。我们将通过三个具体目标实现这些目标。(1)我们将确定DA神经元在突触处是否存在线粒体生物能量功能的内在缺陷。为了做到这一点,我们将用我们新开发的方法来测量单个DA神经元的能量产生和消耗,以评估单个突触突触的线粒体能量水平。(2)我们将通过确定PINK1缺失如何影响DA神经元的线粒体分布和功能,来确定PD蛋白PINK1的缺失是否以及如何影响DA神经元的生物能量功能。(3)我们将通过评估DA神经元在改变活动水平后的功能和死亡来确定神经活动水平是否会使DA神经元更容易受到能量衰竭的影响。
总体而言,这些研究将促进我们对DA神经元是否以及如何发生能量衰竭的理解,并将为我们如何从治疗上针对帕金森病的能量衰竭提供洞察力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEN NAKAMURA其他文献
KEN NAKAMURA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEN NAKAMURA', 18)}}的其他基金
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
制定针对代谢脆弱的人体细胞能量衰竭的策略
- 批准号:
10417270 - 财政年份:2020
- 资助金额:
$ 42.27万 - 项目类别:
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
制定针对代谢脆弱的人体细胞能量衰竭的策略
- 批准号:
10622496 - 财政年份:2020
- 资助金额:
$ 42.27万 - 项目类别:
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
制定针对代谢脆弱的人体细胞能量衰竭的策略
- 批准号:
10237384 - 财政年份:2020
- 资助金额:
$ 42.27万 - 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
- 批准号:
8289649 - 财政年份:2009
- 资助金额:
$ 42.27万 - 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
- 批准号:
8501699 - 财政年份:2009
- 资助金额:
$ 42.27万 - 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
- 批准号:
8231455 - 财政年份:2009
- 资助金额:
$ 42.27万 - 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
- 批准号:
8212953 - 财政年份:2009
- 资助金额:
$ 42.27万 - 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
- 批准号:
7796870 - 财政年份:2009
- 资助金额:
$ 42.27万 - 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
- 批准号:
7659837 - 财政年份:2009
- 资助金额:
$ 42.27万 - 项目类别:
GLUTATHIONE AND DOPAMINERGIC NEURONAL SURVIVAL
谷胱甘肽和多巴胺能神经元的存活
- 批准号:
6185105 - 财政年份:2000
- 资助金额:
$ 42.27万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Establishment of a human, age-specific model for axon growth and regeneration studies
建立用于轴突生长和再生研究的人类特定年龄模型
- 批准号:
9978418 - 财政年份:2020
- 资助金额:
$ 42.27万 - 项目类别:
Understanding the role of mitochondria in the age-related decline in axon regeneration
了解线粒体在与年龄相关的轴突再生衰退中的作用
- 批准号:
10230101 - 财政年份:2020
- 资助金额:
$ 42.27万 - 项目类别:
Modulation of age-related axon loss by systemic and cell-autonomous factors
全身和细胞自主因素对年龄相关轴突损失的调节
- 批准号:
BB/K012983/2 - 财政年份:2015
- 资助金额:
$ 42.27万 - 项目类别:
Training Grant
Modulation of age-related axon loss by systemic and cell-autonomous factors
全身和细胞自主因素对年龄相关轴突损失的调节
- 批准号:
BB/K012983/1 - 财政年份:2013
- 资助金额:
$ 42.27万 - 项目类别:
Training Grant
Age changes in cellular interactions among the endplate components (axon, Schwann cells, acetylcholine receptor, synaptic matrix) during reinnervation to the motor endplate
运动终板重新神经支配过程中终板成分(轴突、雪旺细胞、乙酰胆碱受体、突触基质)之间细胞相互作用的年龄变化
- 批准号:
12670018 - 财政年份:2000
- 资助金额:
$ 42.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AGE, AXON INJURY AND MOTOR NEURON SYNAPTOLOGY
年龄、轴突损伤和运动神经元突触
- 批准号:
2051134 - 财政年份:1991
- 资助金额:
$ 42.27万 - 项目类别:
AGE, AXON INJURY AND MOTOR NEURON SYNAPTOLOGY
年龄、轴突损伤和运动神经元突触
- 批准号:
3121806 - 财政年份:1991
- 资助金额:
$ 42.27万 - 项目类别:
AGE, AXON INJURY AND MOTOR NEURON SYNAPTOLOGY
年龄、轴突损伤和运动神经元突触
- 批准号:
3121804 - 财政年份:1991
- 资助金额:
$ 42.27万 - 项目类别:
QUANTIFYING AND RELATING AGE TO AXON SPROUTING
量化年龄并将其与轴突萌发联系起来
- 批准号:
3397305 - 财政年份:1981
- 资助金额:
$ 42.27万 - 项目类别:
QUANTIFYING AND RELATING AGE TO AXON SPROUTING
量化年龄并将其与轴突萌发联系起来
- 批准号:
3397303 - 财政年份:1981
- 资助金额:
$ 42.27万 - 项目类别:














{{item.name}}会员




